Skip to main content
Clinical Trials/NCT01770548
NCT01770548
Completed
N/A

Autism and Glutamatergic Synapse : Research of Genetic Mutations and Identification of Clinical and Neurophysiological Markers.

University Hospital, Tours4 sites in 1 country497 target enrollmentJanuary 2009
ConditionsAutism

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism
Sponsor
University Hospital, Tours
Enrollment
497
Locations
4
Primary Endpoint
screening of about 50 genes encoding proteins of the NMDA receptor complex, chosen according to their chromosomal localisation located in hotspots depicted by genome-wide screens in large population of autistic patients
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Neurophysiological, Molecular and Developmental Analysis of the glutamate synapse in Autism

Detailed Description

Analysis about 50 genes in glutamate synapse

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
June 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • have a Pervasive Developmental Disorder

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

screening of about 50 genes encoding proteins of the NMDA receptor complex, chosen according to their chromosomal localisation located in hotspots depicted by genome-wide screens in large population of autistic patients

Time Frame: two years

Study Sites (4)

Loading locations...

Similar Trials